Delivery Order SPE2DR25D6028-SPE2DR26FARUH
Award Date 11/17/25
Potential Completion Date 12/9/25
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $12.25K delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Lorbrena 100 mg tablets (30-count units) with delivery expected by December 8, 2025. This competitive award, which carries no set-aside designation, reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The contract represents a firm fixed-price delivery order executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,624.35 on October 29, 2025, for the supply of Lorbrena 100 mg tablets (30-count packaging). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 20, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Lorbrena 100 mg tablets (30-count packaging) with a ceiling value of $24,500.56. This competitively awarded, firm fixed-price delivery order was issued on November 13, 2025, with an ultimate completion date of December 5, 2025. The contract carries no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Lorbrena 25 mg tablets (30-count units) valued at $11,624.34. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award under open market conditions. The contract is scheduled for completion by October 8, 2025, with performance to be fulfilled from the contractor's location in Conshohocken, Pennsylvania. This award represents...
- The Defense Logistics Agency awarded a $11,624.35 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Lorbrena 100 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 21, 2025. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $11,624.35 delivery order to AmerisourceBergen Drug Corp for the supply of Lorbrena 100 mg tablets (30-count units) with a firm fixed price structure and an ultimate completion date of October 14, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026....
- The Defense Logistics Agency awarded a $24.5K delivery order to AmerisourceBergen Drug Corp for 30 tablets of Lorbrena 100 mg on October 22, 2025, with completion scheduled for November 13, 2025. This firm fixed-price contract, issued without set-aside provisions, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction supporting federal medical procurement needs through competitive award procedures. This...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $23,248.72 on September 5, 2025, for the supply of Lorbrena 100 mg tablets (30-count units). This firm fixed-price, competitively awarded contract carries an ultimate completion date of September 26, 2025, and involves performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award contains no set-aside designation, reflecting AmerisourceBergen's...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lorbrena 100mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $23,248.70, is scheduled for completion by August 11, 2025, with performance to be executed at the contractor's Conshohocken, Pennsylvania location. The award was made on a competitive basis with no set-aside designation, reflecting the contractor's...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,688.62 firm fixed-price delivery order is for the supply of LORBRENA 100MG TAB 30S, a pharmaceutical product. The contract has an ultimate completion date of April 23, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...